glp-1 news today cardiovascular outcomes 2025 november Pipeline Update: - Prime Therapeutics Association of GLP-1 inhibitors with

As a medical practice, we often encounter patients who struggle with managing their diabetes and maintaining a healthy weight

Nonetheless, chylomicrons have been reported to be powerful GPR40-Gq activators and GLP-1 secretagogues, acting from the basolateral side of the intestinal mucosa (264)

Newer systematic reviews and meta-analyses suggest a slight increase in pancreatitis overall, although this may not be significant once background medications are considered, and no clear increase in pancreatic cancer has been consistently shown

Adarsha Gowda Food Expert Chairperson/Dean/Head (Former) Entrepreneurship, Startup & Consultancy Dept of Food Science Dept of Food Processing & Engineering

In this, we reinvestigate already FDA-approved drugs for attaining new therapeutic benefits, as these are already in supply chains and have proven clinical safety profiles with shorter timelines

Neural and behavioral markers of inhibitory control predict symptom improvement during internet-delivered cognitive behavioral therapy for depression